SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Net sales declined -12.24%  to  Rs. 4189.62 million from Rs. 4774.14 millions.The company suffered a huge decline of -87.72% to Rs. 214.79  millions from Rs. 1748.77 millions  of corresponding previous quarter.A decline of 767.99 millions was observed in the OP in the quarter ended March 2026 from 2408.65 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 4189.62 4774.14 -12.24 14053.81 12995.89 8.14 14053.81 12995.89 8.14
Other Income 20.93 39.09 -46.46 150.08 176.82 -15.12 150.08 176.82 -15.12
PBIDT 767.99 2408.65 -68.12 2840.01 3869.57 -26.61 2840.01 3869.57 -26.61
Interest 222.52 323.94 -31.31 1205.76 1616.50 -25.41 1205.76 1616.50 -25.41
PBDT 562.17 2084.71 -73.03 1580.05 1130.57 39.76 1580.05 1130.57 39.76
Depreciation 347.38 335.94 3.41 1367.95 1345.12 1.70 1367.95 1345.12 1.70
PBT 214.79 1748.77 -87.72 212.10 -214.55 -198.86 212.10 -214.55 -198.86
TAX 0.00 0.00 0.00 0.00 -414.55 0.00 0.00 -414.55 0.00
Deferred Tax 0.00 0.00 0.00 0.00 -414.55 0.00 0.00 -414.55 0.00
PAT 214.79 1748.77 -87.72 212.10 200.00 6.05 212.10 200.00 6.05
Equity 114.62 114.43 0.17 114.62 114.43 0.17 114.62 114.43 0.17
PBIDTM(%) 18.33 50.45 -63.67 20.21 29.78 -32.13 20.21 29.78 -32.13

Onesource Specialty Share Price

1613.40 -35.80 (-2.17%)
12-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1807.25
Dr. Reddys Lab 1273.90
Cipla 1388.80
Zydus Lifesciences 1104.35
Lupin 2292.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: